Navigation Links
FDA Advisory Committee Recommends Approval of REMICADE® for Treatment of Pediatric Ulcerative Colitis
Date:7/21/2011

n's disease, rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis, ulcerative colitis (UC), pediatric Crohn's disease and psoriasis.  The safety and efficacy of REMICADE® have been well established in clinical trials over the past 17 years and through commercial experience with more than 1.5 million patients treated worldwide.

In the U.S., REMICADE® is approved for the following indications:

  • Reducing signs and symptoms, inhibiting the progression of structural damage and improving physical function in patients with moderately to severely active RA, when administered in combination with methotrexate.  
  • Reducing signs and symptoms in patients with active ankylosing spondylitis.
  • Reducing signs and symptoms and inducing and maintaining clinical remission in adult and pediatric patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy.  
  • Reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in adult patients with fistulizing Crohn's disease.  
  • Reducing signs and symptoms, inducing and maintaining clinical remission and mucosal healing, and eliminating corticosteroid use in patients with moderately to severely active UC who have had an inadequate response to conventional therapy.
  • Reducing signs and symptoms of active arthritis, inhibiting the progression of structural damage and improving physical function in patients with psoriatic arthritis.  
  • Treatment of adult patients with chronic severe plaque psoriasis who are candidates for systemic therapy and when other systemic therapies are medically less appropriate.

REMICADE® is unique among available anti-TNF-alpha biologic therapies.  It is the only anti-TNF-alpha biologic administered directly by caregivers in the clinic or office sett
'/>"/>

SOURCE Janssen Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
2. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
3. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
4. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
7. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
8. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
9. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
10. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
11. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013   BioLife Solutions ... of proprietary clinical grade hypothermic storage and ... and contract aseptic media manufacturer , today announced ... & Regenerative Medicine Congress 2013 this week in ... http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO ) Dr. Aby J. Mathew, BioLife,s ...
(Date:5/23/2013)... SAN DIEGO and PARIS ... VOLC ), a leading developer and manufacturer of ... and treatment of coronary and peripheral vascular disease, today ... V asodilator I ndependent S tenosis ... late breaking clinical trial session at EuroPCR 2013. These ...
(Date:5/23/2013)... LAUSANNE , Switzerland ... 23, 2013 Cenix BioScience, ... developer specialized in RNAi-, miRNA- and high content-driven ... biopharmaceutical group of companies with a focus on ... medical needs, including oncology and companion diagnostics, today ...
Breaking Medicine Technology:BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4
... IOMI ) today announced that Stanley C. Erck, the ... Acumen BioFin,Rodman & Renshaw 9th Annual Healthcare Conference in ... will begin at 9:10 a.m. Eastern,Time in the Kennedy ... Mr. Erck,s presentation will focus on Iomai,s portfolio of ...
... Exelixis, Inc. (Nasdaq:,EXEL) today presented data from ... with albuminuria due to diabetic nephropathy. XL784 is ... enzymes that may,play a role in the pathogenesis ... presented during a poster session (Abstract/Poster PO1030) at,the ...
Cached Medicine Technology:Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5 2Phase 2 Trial Results for Exelixis' XL784 Presented at the 2007 American Society of Nephrology Conference 2Phase 2 Trial Results for Exelixis' XL784 Presented at the 2007 American Society of Nephrology Conference 3Phase 2 Trial Results for Exelixis' XL784 Presented at the 2007 American Society of Nephrology Conference 4
(Date:5/23/2013)... (PRWEB) May 23, 2013 Teen birth rates ... according to new data released today by the ... the teen birth rate dropped at least 15% in 48 ... , There were also dramatic declines among all racial/ethnic groups ... ,     Birth rates declined 40% or more for Hispanic teens ...
(Date:5/23/2013)... To better serve the architecture and ... to announce the release of its new selections ... division products. Provided by Koroseal, a leader in ... and colors represent a sophisticated response to contemporary ... team of Koroseal experts, Modernfold reviewed hundreds of ...
(Date:5/23/2013)... that can cause rapidly progressing, life threatening meningitis and ... we have not known how it attaches to the ... it attaches to the airway to colonise", People can ... symptoms, while some people progress to invasive disease. ... of how the bacterium colonises the airway. Now that ...
(Date:5/23/2013)... to a new market report "Service Delivery Platform (SDP) ... Telecom Application Server; Service Creation Environment; Orchestration Environment] - ... MarketsandMarkets, the SDP Market is expected to reach $6.94 ... 2013 to 2018. , Browse:, , ... , 189 Pages and an in-depth Table ...
(Date:5/23/2013)... May 23, 2013 Verndale, an ... the launch of Current Digital, a business dedicated ... and digital marketing needs. Companies now view content ... business necessity. This can often leave agencies placed ... on preselected software platforms that they may not ...
Breaking Medicine News(10 mins):Health News:Modernfold Debuts New Colors and Patterns for Space Division Products 2Health News:New discovery in fight against deadly meningococcal disease 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 3Health News:Verndale Launches Current Digital, a Technology Partner for Ad and Creative Agencies 2Health News:Verndale Launches Current Digital, a Technology Partner for Ad and Creative Agencies 3
... HealthDay Reporter , TUESDAY, April 10 (HealthDay News) -- U.S. ... -- a man-made version of the hormone progesterone -- may ... will require new labels. The U.S. Food and Drug ... pills -- which include products such as Bayer,s Yaz or ...
... HealthDay Reporter , TUESDAY, April 10 (HealthDay News) ... heart test -- an electrocardiogram, or EKG -- translate into ... heart attacks, hospitalizations for chest pain or the need for ... For people with major abnormalities in their EKG, the ...
... TUESDAY, April 10 (HealthDay News) -- American youngsters have a long ... childhood obesity rate, a new study shows. The U.S. Department ... the childhood obesity rate to 14.6 percent by 2020, and to ... an average of 64 calories a day. Without this reduction ...
... in low- and middle-income countries, and there is an ... help tackle the disease, states an analysis in CMAJ ... more people than HIV/AIDS, tuberculosis and malaria combined. The ... rise through 2030 of 82% in low- and lower-income ...
... be good for your health, particularly when parental support ... Boston University School of Public Health (BUSPH) researcher Emily ... adults in a representative Massachusetts sample reported receiving positive ... Their incidence of mental health and substance abuse problems ...
... American Society of Pediatric Otolaryngology (ASPO) will hold its ... 2012 Combined Otolaryngology Spring Meetings (COSM) - a joint ... During the ASPO meeting, hundreds of pieces of ... panelists will be presented focusing on children,s ear, nose, ...
Cached Medicine News:Health News:Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA 2Health News:EKG Heart Test May Predict Risk in Older Adults 2Health News:EKG Heart Test May Predict Risk in Older Adults 3Health News:Young Americans Need to Cut Calorie Intake: Study 2Health News:Supporting LGB children may influence their long-term health, BU study finds 2Health News:Supporting LGB children may influence their long-term health, BU study finds 3Health News:Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting 2Health News:Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting 3Health News:Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting 4Health News:Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting 5Health News:Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting 6Health News:Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting 7Health News:Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting 8Health News:Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting 9Health News:Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting 10Health News:Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting 11
... The TOPCON 3D+ ALE-3700/3700PC/3700CF patternless processing ... to frame, quickly, accurately and with the ... incorporates the 3D+ FR-20 Frame Reader, advanced ... system is available with a polycarbonate feature ...
... Cutting-edge technology enables a fast, precise ... every time. Introducing the TOPCON ALE-X1. The ... a host of improved features and functions. ... both flat and beveled edges, precise three-dimensional ...
...
... TOPscan Dispensers used to only have two choices ... the completed job at a wholesale lab, which ... alternative was to finish the order in house, ... offices required another edger, lens inventory, more space ...
Medicine Products: